Our findings suggest that CTS exhibits beneficial effects on diabetes-induced cognitive and emotional deficits and that its effects on cognitive deficits are mediated by attenuating diabetes-induced dysfunction of central cholinergic systems, and Akt signaling and VEGF/PDGF systems in the brain. The gene discussed is VEGFA; the disease is diabetes mellitus.